Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial - van Ramshorst, M S; van der Voort, A; van Werkhoven, E D (Lancet Oncol, 2018)